PortfoliosLab logoPortfoliosLab logo
ORCX vs. CDC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ORCX vs. CDC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Daily Target 2X Long ORCL ETF (ORCX) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ORCX achieves a 16.25% return, which is significantly higher than CDC's 10.57% return.


ORCX

1D
-11.49%
1M
55.88%
YTD
16.25%
6M
-1.67%
1Y
15.78%
3Y*
5Y*
10Y*

CDC

1D
-0.57%
1M
-0.39%
YTD
10.57%
6M
10.29%
1Y
18.16%
3Y*
11.97%
5Y*
5.08%
10Y*
10.03%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ORCX vs. CDC - Yearly Performance Comparison


Correlation

The correlation between ORCX and CDC is -0.14, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.14

Correlation (All Time)
Calculated using the full available price history since Feb 10, 2025

0.02

The correlation between ORCX and CDC shifts across timeframes, from -0.14 (1 year) to 0.02 (all time), reflecting how their relationship changes across market environments.

ORCX vs. CDC - Sectors Allocation Comparison


Sectors
ORCX
CDC

Technology

100.0%
6.9%

Basic Materials

-

0.0%

Communication Services

-

4.4%

Consumer Cyclical

-

6.6%

Consumer Defensive

-

15.9%

Energy

-

9.5%

Financial Services

-

23.4%

Healthcare

-

6.8%

Industrials

-

2.3%

Real Estate

-

0.0%

Utilities

-

24.3%

Technology

ORCX
100.0%
CDC
6.9%

Basic Materials

ORCX

-

CDC
0.0%

Communication Services

ORCX

-

CDC
4.4%

Consumer Cyclical

ORCX

-

CDC
6.6%

Consumer Defensive

ORCX

-

CDC
15.9%

Energy

ORCX

-

CDC
9.5%

Financial Services

ORCX

-

CDC
23.4%

Healthcare

ORCX

-

CDC
6.8%

Industrials

ORCX

-

CDC
2.3%

Real Estate

ORCX

-

CDC
0.0%

Utilities

ORCX

-

CDC
24.3%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ORCX vs. CDC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORCX
ORCX Risk / Return Rank: 1515
Overall Rank
ORCX Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
ORCX Sortino Ratio Rank: 2323
Sortino Ratio Rank
ORCX Omega Ratio Rank: 2121
Omega Ratio Rank
ORCX Calmar Ratio Rank: 1111
Calmar Ratio Rank
ORCX Martin Ratio Rank: 1010
Martin Ratio Rank

CDC
CDC Risk / Return Rank: 5858
Overall Rank
CDC Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
CDC Sortino Ratio Rank: 5858
Sortino Ratio Rank
CDC Omega Ratio Rank: 5050
Omega Ratio Rank
CDC Calmar Ratio Rank: 6565
Calmar Ratio Rank
CDC Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORCX vs. CDC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Daily Target 2X Long ORCL ETF (ORCX) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ORCXCDCDifference

Sharpe ratio

Return per unit of total volatility

0.12

1.87

-1.74

Sortino ratio

Return per unit of downside risk

1.25

2.78

-1.54

Omega ratio

Gain probability vs. loss probability

1.14

1.32

-0.18

Calmar ratio

Return relative to maximum drawdown

0.18

3.22

-3.03

Martin ratio

Return relative to average drawdown

0.28

11.37

-11.09

ORCX vs. CDC - Sharpe Ratio Comparison

The current ORCX Sharpe Ratio is 0.12, which is lower than the CDC Sharpe Ratio of 1.87. The chart below compares the historical Sharpe Ratios of ORCX and CDC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ORCXCDCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.12

1.87

-1.74

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.41

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.76

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.02

0.74

-0.76

Drawdowns

ORCX vs. CDC - Drawdown Comparison

The maximum ORCX drawdown since its inception was -85.98%, which is greater than CDC's maximum drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for ORCX and CDC.


Loading charts...

Drawdown Indicators


ORCXCDCDifference

Max Drawdown

Largest peak-to-trough decline

-85.98%

-21.37%

-64.61%

Max Drawdown (1Y)

Largest decline over 1 year

-85.98%

-5.67%

-80.31%

Max Drawdown (3Y)

Largest decline over 3 years

-12.70%

Max Drawdown (5Y)

Largest decline over 5 years

-21.37%

Max Drawdown (10Y)

Largest decline over 10 years

-21.37%

Current Drawdown

Current decline from peak

-64.17%

-2.20%

-61.97%

Average Drawdown

Average peak-to-trough decline

-44.40%

-5.09%

-39.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.49%

1.60%

+55.89%

Volatility

ORCX vs. CDC - Volatility Comparison

Defiance Daily Target 2X Long ORCL ETF (ORCX) has a higher volatility of 36.85% compared to VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) at 2.66%. This indicates that ORCX's price experiences larger fluctuations and is considered to be riskier than CDC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ORCXCDCDifference

Volatility (1M)

Calculated over the trailing 1-month period

36.85%

2.66%

+34.19%

Volatility (6M)

Calculated over the trailing 6-month period

82.26%

6.84%

+75.42%

Volatility (1Y)

Calculated over the trailing 1-year period

127.97%

9.77%

+118.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

121.00%

12.54%

+108.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

121.00%

13.21%

+107.79%

ORCX vs. CDC - Expense Ratio Comparison

ORCX has a 1.29% expense ratio, which is higher than CDC's 0.37% expense ratio.


Dividends

ORCX vs. CDC - Dividend Comparison

ORCX has not paid dividends to shareholders, while CDC's dividend yield for the trailing twelve months is around 3.18%.


PositionTTM20252024202320222021202020192018201720162015
CDC
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
3.18%3.36%3.32%4.24%3.48%2.65%2.48%3.04%3.37%2.81%2.99%3.17%
ORCX
Defiance Daily Target 2X Long ORCL ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


ORCX and CDC have a correlation of -0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ORCX has higher volatility (36.85%) compared to CDC (2.66%). In terms of maximum drawdown, ORCX dropped -85.98% vs CDC's -21.37%.

On 1-year performance, CDC leads with 18.16% vs 15.78% for ORCX. On fees, CDC is cheaper at 0.37% per year. On volatility, CDC has been the lower-risk option at 2.66%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, CDC has performed better with a 18.16% return vs 15.78%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CDC is cheaper with a 0.37% expense ratio, compared with 1.29% for ORCX.

CDC has the higher dividend yield at 3.18%, compared with 0.00% for ORCX.

ORCX is categorized as Leveraged Equities, while CDC is Large Cap Value Equities. They also come from different issuers: Defiance and Crestview. Their fees differ too: 1.29% for ORCX and 0.37% for CDC.

CDC currently has the higher Sharpe Ratio (1.87 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ORCX and CDC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer